Beactica

Activities: Manufacturing Research & Development

Trending Articles

  1. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
  5. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Research & Development

Beactica awarded funding to develop therapeutics against brain tumours

Beactica, the Swedish drug discovery company, announced it has been awarded 2 MSEK (around $240 000) by the Swedish Governmental Agency for Innovation Systems (Vinnova) to advance its LSD1 programme
Research & Development

Beactica appoints Erik Walldén and Uli Hacksell to its Board of Directors
Research & Development

Beactica glioblastoma research with Uppsala Uni and SciLifeLab

Goal of the collaboration to evaluate the pre-clinical efficacy of allosteric modulators of epigenetic protein LSD1
Research & Development

Beactica and Almac agree drug discovery collaboration

Beactica to use its Sprint discovery platform to identify targets of interest to Almac
Subscribe now